Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01852656 · ClinicalTrials.gov registry record · NA
Effectiveness of Influenza Vaccine Reminder Systems
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 12,255
- Enrollment target
NCT01852656 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 12,255 participants.
The verdict
NCT01852656, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,255 participants
- Enrollment target
Study Summary
Influenza disease causes significant morbidity and mortality in the Unites States each year. Although influenza can cause morbidity in otherwise healthy individuals, adults with chronic lung disease have significantly increased rates of hospitalization from influenza-related illnesses compared to healthy adults. Influenza vaccination is the primary means of preventing influenza disease. Annual influenza vaccination is recommended for all individuals 6 months of age and older in the United States. Influenza vaccination rates are sub-optimal, however. Patient reminder/recall has been shown, in multiple studies across a variety of age groups and health conditions, to increase immunization rates. However, the effectiveness and cost-effectiveness of different types of reminder/recall has not been well-studied, particularly in adults. In the fall of 2012, the Population and Prevention Services (PPS) Department at Kaiser Permanente Colorado (KPCO) is using 3 different reminder strategies for influenza vaccination among adults with asthma and chronic obstructive pulmonary disease (COPD). The objective of this study is to provide a rigorous evaluation of which strategy is more effective and more cost-effective, to promote influenza vaccination.
Interventions
- BEHAVIORAL Postcard and IVR Reminder Group
- BEHAVIORAL Postcard Only Reminder Group
- BEHAVIORAL IVR Only Reminder Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,255 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01852656
The ClinicalTrials.gov registry entry for NCT01852656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12,255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Postcard and IVR Reminder Group is the first listed.
NCT01852656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01852656 about?
NCT01852656 is a clinical study titled "Effectiveness of Influenza Vaccine Reminder Systems". Influenza disease causes significant morbidity and mortality in the Unites States each year. Although influenza can cause morbidity in otherwise healthy individuals, adults with chronic lung disease have significantly increased rates of hospitalization from influenza-related illnesses compared to he...
What is the current status of trial NCT01852656?
This trial is currently completed. It is a NA study. The enrollment target is 12,255 participants. The study started on 2012-09. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01852656?
The interventions under investigation include: Postcard and IVR Reminder Group (BEHAVIORAL), Postcard Only Reminder Group (BEHAVIORAL), IVR Only Reminder Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01852656?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.